• Isocyanic acid,hydrogenated tallow alkyl esters
• 91671-81-7
• 293-983-2
• .

• Indeno[1,2-c]pyrazol-4-ol,4-[3-(dimethylamino)propyl]-2-ethyl-2,4-dihydro-3-methyl-
• 68946-10-1
• C18H25 N3 O
• 0
• .

• Imidazo[1,2-c]quinazolin-5(3H)-one,2,6-dihydro-
• 38767-52-1
• C10H9 N3 O
• 187.198
• .

• Indolo[2,3-a]carbazole,3,8-dichloro-11,12-dihydro-
• 139083-25-3
• C18H10 Cl2 N2
• .

• Isoundecanoic acid,lead(2+) salt (9CI)
• 93965-29-8
• C11H22 O2 . 1/2 Pb
• 300-979-7
• 577.76648
• .

• Imidazo[1,2-f]phenanthridine,7-chloro-2,3-dihydro-
• 38040-79-8
• C15H11 Cl N2
• 254.7142
• .

• Imidodiphosphoroustetrachloride, N-phenyl-
• 39652-40-9
• C6H5 Cl4 N P2
• 294.8701
• .

• Isoquinolinium,2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,(1R,1'R,2R,2'R)-
• 96946-41-7
• C53H72 N2 O12
• 929.1439
• .

• Isooctanesulfonamide,heptadecafluoro-N-methyl- (9CI)
• 93894-71-4
• C₉H₄F₁₇NO₂S
• 299-771-6
• 513.1714144
• .

• Isoquinoline,3-(2-ethylphenyl)-1,2,3,4-tetrahydro-
• 30331-81-8
• C17H19 N
• .

• Isooctanesulfonamide,heptadecafluoro-N,N-bis(2-hydroxyethyl)- (9CI)
• 93894-66-7
• C12H10 F17 N O4 S
• 299-766-9
• 587.2499544
• .

• Isoquinoline,1-methoxy-
• 23724-93-8
• C10H9 N O
• 159.1846
• .

• Isoquinolinium,2-(2,5-dihydroxyphenyl)-, chloride (1:1)
• 6276-22-8
• C15H12 N O2 . Cl
• 238.2607
• .

• Isoquinoline-8-d,1,2,3,4-tetrahydro-6,7-dimethoxy-1-[(4-methoxyphenyl-3,5-d2)methyl]-2-methyl-(9CI)
• 7240-67-7
• C20H22 D3 N O3
• 396.3742
• .

• Isoquassinic acid (9CI)
• 89678-55-7
• 0
• .

• INO 3178 (9CI)
• 74188-25-3
• .

• Iron,(isononanoato-O)(isooctanoato-O)- (9CI)
• 93920-17-3
• C17H32 Fe O4
• 300-101-2
• .

• Insulin-like growthfactor II (human reduced) (9CI)
• 67512-18-9
• C321H505 N93 O101 S6
• 154.24932
• .

• Isohexadecenal (9CI)
• 85926-92-7
• C16H30 O
• 288-867-3
• 238.4088
• .

• Isotritriacontane (9CI)
• 90398-67-7
• C33H68
• 464.893
• .

• Imidazo[2,1-b]thiazole-5-carboxaldehyde,6-chloro-2,3-dihydro-, oxime
• 83253-31-0
• C6H6 Cl N3 O S
• 203.6493
• .

• Isoquinolinium,2,2'-[[(4E)-1,8-dioxo-4-octene-1,8-diyl]bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-,(1R,1'R)-
• 133814-19-4
• C₅₈H₈₀N₂O₁₄
• 1029.2597
• .

• Isoton (9CI)
• 77904-49-5
• 0
• .

• Isoxazole,5-[5-[4-(4,5-dihydro-2-oxazolyl)-2-(1,1-dimethylethyl)phenoxy]pentyl]-3-methyl-
• 105639-09-6
• C22H30 N2 O3
• 370.4852
• .

• Isoxazole,5-[5-[4-(4,5-dihydro-2-oxazolyl)-2-(1-methylethyl)phenoxy]pentyl]-3-methyl-
• 105639-08-5
• C21H28 N2 O3
• 356.4586
• .

• Ibogamine-18-carboxylicacid, 14-[(3a,20b)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-13-methoxy-19-(2-oxopropyl)-,methyl ester, (19R)- (9CI)
• 58917-03-6
• C46H58 N4 O6
• .

• Imidazo[1,2-a]pyridine,2-(4-nitrophenyl)-3-(1-piperidinylmethyl)-
• 3323-00-0
• C19H20 N4 O2
• 336.3877
• .

• Imidazo[2,1-b]thiazole,3-[3-chloro-4-(pentyloxy)phenyl]-5,6-dihydro-, hydrochloride (1:1)
• 160518-41-2
• C16H19 Cl N2 O S . Cl H
• 0
• .

• Inosine,1-(phenylmethyl)-
• 31504-19-5
• C17H18 N4 O5
• 358.3486
• .

• Iron, dicarbonyl(h5-2,4-cyclopentadien-1-yl)(2-pyridinylmethyl)-
• 12215-40-6
• C13H11 Fe N O2
• 265.04518 [g/mol]
• .

• Isoxazole, 3-methyl-
• 30842-90-1
• C₄H₅NO
• 83.0886
• .

• Isooctadecanoic acid,dodecyl ester
• 93803-85-1
• C30H60 O2
• 298-359-3
• 452.7962
• .

• Imidazo[1,5-a]pyrazine,3-[(phenylsulfonyl)methyl]-
• 55316-53-5
• C13H11 N3 O2 S
• 273.3103
• .

• Inosine 5'-(trihydrogendiphosphate), P'-anhydride with phosphorothioic acid
• 77065-87-3
• C10H15 N4 O13 P3 S
• 0
• .

• Iron sulfide
• 11126-12-8
• FeS
• 234-367-5
• 207.885
• .

• Imidazo[2,1-b]thiazole,2,3-dihydro-6-(methylphenyl)-5-nitro- (9CI)
• 96125-79-0
• C12H11 N3 O2 S
• 259.28376
• .

• Isothiazolidine,2-phenyl-, 1,1-dioxide
• 76906-24-6
• C9H11 N O2 S
• 197.2541
• .

• Isooctanoic acid, leadsalt, basic
• 90431-26-8
• 291-549-7
• .

• Iron,aqua[8,13-diethyl-N-[3-(1H-imidazol-1-yl)propyl]-3,7,12,17-tetramethyl-21H,23H-porphine-2-propanamidato(2-)]-,(OC-6-43)- (9CI)
• 50867-87-3
• C37H43 Fe N7 O2
• 673.628
• .

• Imidazo[2,1-b]thiazole,2,3-dihydro-5-nitro-, 1,1-dioxide
• 65092-09-3
• C5H5 N3 O4 S
• 203.1759
• .

• Ilamycin (8CI,9CI)
• 11006-41-0
• .

• Isoquinoline,1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-propyl-
• 65700-38-1
• C23H31 N O4
• 385.4965
• .

• Inosine 5'-(trihydrogenpyrophosphate), 5'®5'-ester with 4-cyano-1,4-dihydro-1-b-D-ribofuranosylnicotinamide (8CI)
• 5839-31-6
• C22H27 N7 O15 P2
• 339.3022
• .

• Iron,tetracarbonyl[(2,3-h)-2,4-dimethyl-2,3-pentadiene]- (9CI)
• 12264-26-5
• C11H12 Fe O4
• 168.89016 [g/mol]
• .

• Inosine,3'-deoxy-3'-(N-methylacetamido)-, 2',5'-diacetate (8CI)
• 25787-55-7
• C17H21 N5 O7
• 407.3779
• .

• Iron, aminomethylateddivinylbenzene-ethenylethylbenzene-styrene polymer EDTA complexes
• 114060-60-5
• 0
• .

• Iron, bis[(1,2,3,4,5-h)-2,3,4-trimethyl-2,4-pentadienyl]-(9CI)
• 112426-34-3
• C16H26 Fe
• 0
• .

• Imidazo[1,2-a]pyridinium,2-[4-[[2-[(hydroxyamino)iminomethyl]hydrazinylidene]methyl]phenyl]-1,7-dimethyl-,bromide, hydrobromide (1:1:1)
• 123510-46-3
• C17H19 N6 O . Br H . Br
• 484.1883
• .

• Indium chloride(InCl3), tetrahydrate (8CI,9CI)
• 22519-64-8
• Cl₃In^.4H₂O
• 233-043-0
• 293.2381
• .

• Iron,tris(1,3-diphenyl-1,3-propanedionato-kO1,kO3)-, (OC-6-11)-
• 14405-49-3
• C45H33 Fe O6
• 725.58
• .